Ono Pharmaceutical Co., Ltd. (OPHLY) Financials

OPHLY Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 6.6 billion 1.3 billion
March 31, 2026 7.0 billion 1.6 billion
Dec. 31, 2025 6.9 billion 1.5 billion
Sept. 30, 2025 7.3 billion 1.7 billion

OPHLY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -5.8 million ?
March 31, 2026 311.7 million ?
Dec. 31, 2025 204.4 million ?
Sept. 30, 2025 346.0 million ?

OPHLY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 150.4 million
March 31, 2026 5.2 million
Dec. 31, 2025 187.6 million
Sept. 30, 2025 154.7 million

OPHLY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 1.4 billion 412.3 million 44.5 million
March 31, 2026 1.5 billion 471.6 million 47.0 million
Dec. 31, 2025 1.2 billion 575.4 million 48.4 million
Sept. 30, 2025 1.3 billion 617.8 million 52.1 million

OPHLY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 8.7 million
March 31, 2026 9.1 million
Dec. 31, 2025 9.0 million
Sept. 30, 2025 9.6 million

OPHLY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 12.4 million 201.9 million 148.9 million -
March 31, 2026 6.3 million 270.9 million 196.3 million -
Dec. 31, 2025 6.6 million 217.9 million 206.2 million -
Sept. 30, 2025 11.5 million 239.0 million 206.8 million -

OPHLY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 723.6 million 178.6 million
March 31, 2026 757.1 million 210.8 million
Dec. 31, 2025 909.1 million 238.4 million
Sept. 30, 2025 890.9 million 240.4 million

OPHLY

Price: $5.17

52 week price:
3.32
5.75

Dividend Yield: 3.49%

Payout Ratio Range:
5.85%
98.43%

Earnings Per Share: 0.31 USD

P/E Ratio: 15.55

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - General

Market Capitalization: 6.8 billion

Links: